[1]
|
Ping, J., Rong, S., Jing, Z., Liang, F., Qiaojun, H. and Yongzhou, H. (2008) Design, synthesis and evaluation of galanthamine derivatives as acetylcholinesterase inhibitors. European Journal of Medicinal Chemistry, 44 (12), 772-784.
|
[2]
|
Traykova, M., Traykov, T., Hadjimitova, V., Krikorian, K. and Bojadgieva, N. (2003) Antioxidant Properties of Galantamine Hydrobromide. Zeitschrift für Naturforschung, 58c, 361-365.
|
[3]
|
Heinrich, M. and Teoh, H.L. (2004) Galanthamine from snowdrop-the development of a modern drug against Alzheimer's disease from local Caucasian knowledge. Journal of Ethno pharmacology, 92, 147-162.
|
[4]
|
Scott, L.J. and Goa, K.L. (2000) Galantha mine: A review of its use in Alzheimer's disease. Adis Review, 60(5), 1095-122.
|
[5]
|
Novikova, I.Y. and Tulaganov, A.A. (2002) Physicochemical methods for the analysis of galanthamine (review). Pharmaceutical Chemistry Journal, 36(11), 623-627.
|